Chemopreventive efficacy of lycopene on 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis

The chemopreventive efficacy of lycopene on 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinogenesis was examined using lipid peroxidation, reduced glutathione (GSH), glutathione peroxidase (GPx), glutathione S-transferase (GST) and glutathione reductase (GR) as biomarkers of chemoprevention. Twenty four male Syrian hamsters were divided into four groups of six animals each. The right buccal pouches of the animals in group 1 were painted with a 0.5% solution of DMBA in liquid paraffin three times a week. The animals in group 2 were painted with DMBA as in group 1 and in addition received 2.5 mg/kg body weight lycopene orally three times a week on days alternate to DMBA application. Group 3 animals received lycopene as in group 2. Animals in group 4 received neither DMBA nor lycopene and served as control. The hamsters were killed after an experimental period of 14 weeks. Biochemical measurements were carried out in tumour and normal tissues. All hamsters painted with DMBA alone for 14 weeks developed well-differentiated squamous cell carcinomas. Diminished lipid peroxidation in the oral tumour tissue was accompanied by a significant increase in the levels of GSH, GPx, GST and GR. Administration of lycopene significantly suppressed DMBA-induced oral carcinogenesis as revealed by the absence of carcinomas. The results of the present study suggest that lycopene may exert its chemopreventive effects by modulating lipid peroxidation and enhancing the activities of the enzymes in the glutathione redox cycle.     

改良低聚果糖口服补液盐对兔腹泻的临床试验

改良低聚果糖口服补液盐,使其具有调节微生态、补充VB1等作用,并应用于临床兔腹泻的防治.在腹泻预防试验中,改良低聚果糖口服补液盐、低聚果糖口服补液盐组和空白对照腹泻发病率分别为3.7%、12%、60%;在腹泻的治疗试验中,改良低聚果糖口服补液盐对腹泻症的治疗有效率达到89.1%;在腹泻和其他药物的治疗对照试验中,改良低聚果糖口服补液盐、低聚果糖口服补液盐组、黄连素组、空白对照,对腹泻症的治疗有效率分别为90.9%、78.9%、58.3%、18.8%.     

参金止痢口服液对腹泻哺乳仔猪肠道微生物菌群影响的差异性分析

研究参金止痢口服液对腹泻哺乳仔猪肠道微生物菌群的影响。选取同等饲养条件下7~15日龄体重相近的“杜×长×大”三元杂交仔猪共计9头,其中有腹泻症状的6头将其随机平均分为腹泻空白组(FXK)和腹泻中药组(FZ),正常的3头为健康空白组(JK),中药组灌服参金止痢口服液,空白组灌服同等体积生理盐水,连续灌胃5d,在给药后的第8天对仔猪采血进行抗体及细胞因子水平测定,并采集结肠内容物提取样本中菌群总DNA进行16S rRNA高通量测序。结果显示：与FXK组相比,FZ组血清中IgG含量显著升高(P＜0.05),IgM含量显著降低(P＜0.05),炎性因子IL-1β、IL-6、TNF-α含量显著下调(P＜0.01)。α、β多样性分析结果表明,三个组结肠肠道菌群结构差异显著。在门分类水平上,FZ组仔猪肠道拟杆菌门相对丰度显著高于FXK组(P＜0.05),变形菌门相对丰度显著低于FXK组(P＜0.05),而FZ与JK组之间两个菌门差异不显著。属水平上,FZ组韦荣球菌属和乳杆菌属相对丰度显著低于FXK组(P＜0.05),普雷沃氏菌属相对丰度显著高于FXK组(P＜0.05),FZ组与JK组之间这三个菌属差异不显著。综上结果表明,参金止痢口服液可能通过调节免疫及炎性相关因子水平和调节肠道菌群结构从而发挥治疗哺乳仔猪腹泻的作用。     

Comparative responses to sodium selenite and organic selenium supplements in Belgian Blue cows and calves

Belgian Blue (BB) beef cattle is particularly prone to selenium (Se) deficiency due to the poor Se content of soil and roughages on rearing farms and the higher requirements of this hypermuscled breed. The goal of this trial was to compare the effects of different forms and concentrations of Se supplementation on Se status, health and performance in 60 pregnant Se-deficient BB cows. Cows were allocated to 3 experimental groups receiving selenized-yeast at 0.5 ppm Se on total ration (Y–Se 0.5), Na–selenite at 0.5 ppm Se on total ration (Na–Se 0.5) and Na–selenite at 0.1 ppm Se on total ration (Na–Se 0.1), respectively. Cows were supplemented from 2 months before calving until 2 months after calving. Data on performance, health and Se status of the dams and their calves were analyzed using a linear model, least squares means and logistic regression. At the end of the study, plasmatic Se (pSe) was significantly higher (P < 0.01) in cows receiving Y–Se than in cows from other groups. Glutathion-peroxidase in erythrocytes (GSH-pxe) was higher in Y–Se and Na–Se 0.5 than Na–Se 0.1 group (P < 0.01). Se content in colostrum and milk was significantly higher (P < 0.01) in Y–Se than other groups. At birth, Se status of calves from group Y–Se was significantly higher than those of other groups (P < 0.01). Plasmatic Se in calves remained higher for 75 days after birth in Y–Se compared to other groups (P < 0.01). Diarrhoea was the most commonly observed disease in the calves and, during the first 15 days of life, diarrhoea occurred in 6%, 21% and 35% of calves from groups Y–Se, Na–Se 0.5 and Na–Se 0.1, respectively. Over the whole 75 days trial period, incidence of diarrhoea was 19, 29 and 65%, respectively. Average daily gain (ADG) in calves born from Y–Se group of cows tended to be higher than in Na–Se 0.5 (P = 0.06) and Na–Se 0.1 (P < 0.05) but there was no difference between Na–Se 0.5 and Na–Se 0.1 (P > 0.1). At the same dosage, Y–Se conferred better Se status in both dams and their calves than did Na–Se. Requirement of 0.1 ppm Se seems to be insufficient in BB to optimise health and performance. Regarding health status and ADG in calves, Y–Se seems also to result in better performance.     

双葛止泻口服液微生物限度检查方法学验证

建立了双葛止泻口服液的微生物限度检查方法.根据2015年版《中华人民共和国兽药典(二部)》通则1102非无菌产品微生物限度检查:微生物计数法,以及通则1103非无菌产品微生物限度检查:控制菌检查法和通则1104非无菌兽药微生物限度标准进行方法适用性试验.结果 表明,采用薄膜过滤法对样品进行需氧菌总数、霉菌和酵母菌计数方...     

Efficacy of an oral live vaccine for veterinary use against pseudotuberculosis

Pseudotuberculosis, an infection caused by the ubiquitous enteropathogenic bacterium Yersinia pseudotuberculosis, is a recurrent veterinary problem in livestock and zoo animals. The only vaccine currently available in zoos is Pseudovac (a mixture of killed strains of various serotypes), but its efficacy is not well established. We show here that Pseudovac does not protect guinea pigs against a severe Y. pseudotuberculosis infection. We thus evaluated the possibility of using a live attenuated Y. pseudotuberculosis strain (IP32680) as an oral vaccine against animal pseudotuberculosis. We report that IP32680 is avirulent for guinea pigs and induces a strong IgG response against various serotypes of Y. pseudotuberculosis. One and two oral inoculations of IP32680 provided 50% and 83% protection, respectively against a severe infection with a highly pathogenic strain. The avirulent Y. pseudotuberculosis IP32680 is therefore much more protective than Pseudovac and may represent a valuable oral vaccine against pseudotuberculosis in zoo animals.     

加味雏痢净口服液的制备工艺研究

建立治疗雏鸡白痢的中药复方口服液加味雏痢净的制备工艺。以加水倍数、煎煮次数、煎煮时间为考察因素,以黄芩苷、连翘酯苷A的总含量和浸出物的综合评分为评价指标,在单因素试验的基础上,采用Box-Behnken响应面设计法对该口服液的制备工艺条件进行优化。结果表明,味雏痢净口服液的最佳制备工艺为加水倍数为12倍,煎煮次数2次,煎煮时间1 h,在此条件下三次验证试验表明黄芩苷和连翘酯苷A总含量可达5.53 mg.mL_-1^,浸出物为15.89%,综合评分93.76分。该方法优化的工艺稳定可靠,科学可行,可为加味雏痢净口服液的工艺研究和规模化生产提供参考。